Skip to main content
Premium Trial:

Request an Annual Quote

Sema4 Partners With PWNHealth on Consumer Genetic Testing

NEW YORK (GenomeWeb) – Sema4, a sequencing and informatics startup spun out of New York's Mount Sinai Health System this year, is partnering with telehealth company PWNHealth to offer physician-backed genetic testing to consumers nationwide.

The two companies announced today that New York-based PWN Health will supply physician oversight services to Sema4's recently launched CarrierCheck product. CarrierCheck is a genetic carrier test that screens for 67 inherited conditions.

Under the agreement, PWNHealth will review the health history of each consumer who purchases a Sema4 CarrierCheck test to maker sure that the genetic test is appropriate. PWNHealth will then offer genetic counseling services to those whose tests are approved.

"Partnering with PWNHealth helps enable Sema4 to scale up for nationwide consumer orders for genetic testing. PWN's expert clinical team supports our ambition to expand the pathways for consumers to engage in safe, convenient and accessible genetic testing and genetic counseling," Sema4 CEO Eric Schadt said in a statement.

Schadt added that his company expects to work with PWNHealth on future testing products.

Stamford, Connecticut-based Sema4 has been busy forming partnerships of late. Last month, The company teamed with Alexa Pharmaceuticals last month on diagnosis of rare diseases. In June, Sema4 brought in GNS Healthcare for machine learning and simulation services.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.